Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart

被引：0
|
作者：
A. M. Peiró
M. Farré
P. N. Roset
M. Carbó
M. Pujadas
M. Torrens
J. Camí
R. de la Torre
机构：
[1] IMIM-Hospital del Mar Medical Research Institute,Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme
[2] Universitat Autònoma de Barcelona (UDIMAS-UAB),CIBER de Fisiopatología de la Obesidad y Nutrición (CB06/03)
[3] Universitat Pompeu Fabra (CEXS-UPF),undefined
[4] Addiction Unit - INAD,undefined
[5] Doctor Aiguader 88,undefined
[6] CIBEROBN,undefined
来源：
Psychopharmacology | 2013年 / 225卷
关键词：
MDMA; Ecstasy; Repeated dose; Humans; Metabolic inhibition; Pharmacologic effects; Pharmacokinetics; CYP2D6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 893
页数：10
相关论文
共 50 条
  • [11] Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'')
    Cohen, RS
    Cocores, J
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (04) : 727 - 734
  • [12] A review on the mitochondrial toxicity of "ecstasy" (3,4-methylenedioxymethamphetamine, MDMA)
    Capela, Joao Paulo
    Carvalho, Felix Dias
    CURRENT RESEARCH IN TOXICOLOGY, 2022, 3
  • [13] The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats
    Mechan, AO
    Esteban, B
    O'Shea, E
    Elliott, JM
    Colado, MI
    Green, AR
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) : 170 - 180
  • [14] The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)
    Cole, JC
    Sumnall, HR
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2003, 27 (03) : 199 - 217
  • [15] Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat
    Upreti, Vijay V.
    Eddington, Natalie D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (04) : 1593 - 1605
  • [16] MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves
    Parrott, AC
    NEUROPSYCHOBIOLOGY, 2004, 50 (04) : 329 - 335
  • [17] Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)
    Wieckiewicz, Gniewko
    Danel, Dariusz
    Piegza, Magdalena
    Gorczyca, Piotr
    Pudlo, Robert
    PSYCHIATRIA POLSKA, 2022, 56 (05) : 1109 - 1130
  • [18] (±)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats
    Morley, KC
    McGregor, IS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 408 (01) : 41 - 49
  • [19] Post-Mortem (Re)Distribution of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Human and Animal Data
    De Letter, Els A.
    Stove, Christophe P.
    Lambert, Willy E.
    Piette, Michel H. A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (05) : 453 - 459
  • [20] ASSESSMENT OF THE DISCRIMINATIVE STIMULUS EFFECTS OF THE OPTICAL ISOMERS OF ECSTASY (3,4-METHYLENEDIOXYMETHAMPHETAMINE, MDMA)
    BAKER, LE
    BROADBENT, J
    MICHAEL, EK
    MATTHEWS, PK
    METOSH, CA
    SAUNDERS, RB
    WEST, WB
    APPEL, JB
    BEHAVIOURAL PHARMACOLOGY, 1995, 6 (03): : 263 - 275
12345